Carcinomas of salivary glands click to access explanations in the original CAP template

** Please also refer to H&N biomarker protocol (HeadNeckBiomarkers 2.3.0.0, Apr-2026) for possible ancillary testings.

## The following scenarios are not considered T category defining “bone invasion”:
1) Destruction of intrinsic sinus bone in sinonasal primaries;
2) Erosion of cortical bone;
3) Primary intraosseous (central) salivary gland tumors.

** Please also refer to additional specimens and frozen sections for margin status.

** Please include also intraparotid and periparotid lymph nodes, in addition to the lymph nodes of the neck dissections.


pT0: No evidence of primary tumor
pTis: Carcinoma in situ
pT1: Tumor is less than or equal to 2 cm in greatest dimension without extraparenchymal extension#
pT2: Tumor is greater than 2 cm but less than or equal to 4 cm in greatest dimension withoutextraparenchymal extension#
pT3: Tumor is greater than 4 cm and / or gross extraparenchymal extension (for major salivary glands)#
pT4a: Tumor invades any immediately adjacent structures, including: skin, bone, cartilage, solid organ parenchyma, esophagus, trachea, named nerve##
pT4b: Tumor invades beyond any adjacent structures, including: encasement of carotid artery, base of skull invasion (except nasopharynx), spinal column invasion, intracranial invasion, orbital apex, prevertebral space, mediastinal structures, masticator space
pT4 (subcategory cannot be determined)

# Extraparenchymal extension is clinical or macroscopic evidence of invasion of soft tissues or nerve, except those listed under T4a and T4b. Microscopic evidence alone does not constitute extraparenchymal extension for classification purposes.
## The following scenarios are not considered T category defining “bone invasion”: 1) Destruction of intrinsic sinus bone in sinonasal primaries; 2) Erosion of cortical bone; 3) Primary intraosseous (central) salivary gland tumors.